News

27/05/2025

Telara Pharma Earns Emerging Company Certification from Enisa

Receiving the Emerging Company Certification is a powerful validation of Telara Pharma’s innovative approach.

01/10/2024

Telara Pharma awarded €841.000 from call Public-private partnership from Spanish government

To characterize the mechanism of action of cilastatin to act as a preventive treatment in acute and chronic inflammatory indications.

01/02/2024

Telara Pharma has been awarded a €325,000 non-refundable grant through the Spanish Ministry of Science and Innovation Neotec programme

Neotec is a highly competitive programme that aims to foster technology and innovation for the development of companies based in Spain.